Cargando…
Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach
Hepatocellular carcinoma (HCC) is a leading cause of death globally. Even though the progressive invention of some very potent therapeutics has been seen, the success is limited due to the chemotherapeutic resistance and recurrence in HCC. Advanced targeted treatment options like immunotherapy, mole...
Autores principales: | Dhara, Moumita, Al Hoque, Ashique, Sen, Ramkrishna, Dutta, Debasmita, Mukherjee, Biswajit, Paul, Brahamacharry, Laha, Soumik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875447/ https://www.ncbi.nlm.nih.gov/pubmed/36694259 http://dx.doi.org/10.1186/s12951-022-01764-4 |
Ejemplares similares
-
Bioactivity of 2′-deoxyinosine-incorporated aptamer AS1411
por: Fan, Xinmeng, et al.
Publicado: (2016) -
Insights into the binding mode of AS1411 aptamer to nucleolin
por: Bie, Lihua, et al.
Publicado: (2022) -
Anti-nucleolin aptamer AS1411: an advancing therapeutic
por: Van den Avont, Alexander, et al.
Publicado: (2023) -
Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy
por: Salave, Sagar, et al.
Publicado: (2022) -
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability
por: Piazzini, Vieri, et al.
Publicado: (2018)